Edesa Biotech, Inc. (EDSA)

Edesa Biotech Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	12.05	10.79	1.04	5.36	7.09	7.84
Cash & Short-Term Investments	12.05	10.79	1.04	5.36	7.09	7.84
Cash Growth	670.82%	940.39%	-80.65%	-24.39%	-9.55%	8.67%
Accounts Receivable	0.43	0.64	0.27	0.63	1.26	3.3
Other Current Assets	0.23	0.08	0.37	0.45	0.75	0.95
Total Current Assets	12.72	11.51	1.68	6.44	9.09	12.09
Net Property, Plant & Equipment	-	-	0.02	0.1	0.03	0.11
Other Intangible Assets	1.95	1.98	2.08	2.18	2.28	2.38
Other Long-Term Assets	0.04	0.04	0.04	0.17	0.17	-
Total Assets	14.71	13.53	3.81	8.89	11.58	14.58
Accounts Payable	0.76	1.08	1.81	1.75	2.12	1.38
Current Portion of Leases	-	-	0.02	0.07	0.02	0.08
Total Current Liabilities	0.76	1.08	1.83	1.82	2.14	1.46
Long-Term Leases	-	-	-	0.02	-	0.02
Other Long-Term Liabilities	-	-	-	-	0.04	0.05
Total Long-Term Liabilities	-	-	-	0.02	0.04	0.07
Total Liabilities	0.76	1.08	1.83	1.84	2.18	1.53
Common Stock	67.2	63.78	47.24	46.64	42.47	34.89
Additional Paid-in Capital	15.12	14.75	13.58	13.04	11.18	4.87
Accumulated Other Comprehensive Income	-0.17	-0.17	-0.24	-0.21	-0.21	-0.21
Retained Earnings	-68.2	-65.91	-58.59	-52.42	-44.04	-26.5
Total Common Shareholders' Equity	13.95	12.45	1.98	7.05	9.39	13.06
Shareholders' Equity	13.95	12.45	1.98	7.05	9.39	13.06
Total Liabilities & Equity	14.71	13.53	3.81	8.89	11.58	14.58
Total Debt	-	0	0.02	0.09	0.02	0.1
Net Cash (Debt)	12.05	10.79	1.02	5.27	7.07	7.74
Net Cash Growth	11.67%	960.70%	-80.68%	-25.52%	-8.63%	9.79%
Net Cash Per Share	-	-	-	-	3.07	4.45
Book Value	13.95	12.45	1.98	7.05	9.39	13.06
Book Value Per Share	-	-	-	-	4.08	7.50
Tangible Book Value	12	10.47	-0.1	4.87	7.11	10.68
Tangible Book Value Per Share	-	-	-	-	3.09	6.14

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q